BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 120 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $4,155,000 | +1.2% | 510,408 | +0.4% | 0.00% | 0.0% |
Q4 2018 | $4,104,000 | -46.8% | 508,508 | -49.7% | 0.00% | 0.0% |
Q3 2018 | $7,708,000 | +149.9% | 1,010,212 | +87.7% | 0.00% | +50.0% |
Q2 2018 | $3,084,000 | +17.9% | 538,295 | -1.8% | 0.00% | 0.0% |
Q1 2018 | $2,615,000 | -3.1% | 548,146 | -0.2% | 0.00% | 0.0% |
Q4 2017 | $2,698,000 | +2.6% | 549,401 | +9.5% | 0.00% | 0.0% |
Q3 2017 | $2,630,000 | +0.9% | 501,930 | +7.0% | 0.00% | 0.0% |
Q2 2017 | $2,607,000 | -11.9% | 468,882 | +33.2% | 0.00% | 0.0% |
Q1 2017 | $2,958,000 | +29.8% | 352,100 | -2.2% | 0.00% | 0.0% |
Q4 2016 | $2,279,000 | +34.1% | 360,022 | -6.6% | 0.00% | +100.0% |
Q3 2016 | $1,699,000 | +54.2% | 385,339 | -0.7% | 0.00% | 0.0% |
Q2 2016 | $1,102,000 | +19.1% | 388,150 | +18.7% | 0.00% | 0.0% |
Q1 2016 | $925,000 | -72.6% | 326,873 | 0.0% | 0.00% | -66.7% |
Q4 2015 | $3,373,000 | -12.4% | 326,873 | -3.2% | 0.00% | 0.0% |
Q3 2015 | $3,850,000 | -26.5% | 337,717 | -3.7% | 0.00% | -25.0% |
Q2 2015 | $5,236,000 | +64.2% | 350,731 | -0.7% | 0.00% | +100.0% |
Q1 2015 | $3,188,000 | -25.6% | 353,038 | +0.1% | 0.00% | -33.3% |
Q4 2014 | $4,287,000 | +19.1% | 352,554 | -4.2% | 0.00% | 0.0% |
Q3 2014 | $3,601,000 | -19.6% | 368,154 | +4.8% | 0.00% | 0.0% |
Q2 2014 | $4,478,000 | +55875.0% | 351,228 | +7088.5% | 0.00% | – |
Q2 2013 | $8,000 | – | 4,886 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 3,846,154 | $62,538,000 | 25.44% |
ORACLE INVESTMENT MANAGEMENT INC | 1,720,733 | $27,979,000 | 5.53% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 57,000 | $19,282,000 | 4.35% |
MPM BioImpact LLC | 639,089 | $10,392,000 | 2.79% |
Parkman Healthcare Partners LLC | 476,978 | $7,756,000 | 2.27% |
Sarissa Capital Management LP | 1,390,790 | $22,614,000 | 2.14% |
Ghost Tree Capital, LLC | 350,000 | $5,691,000 | 1.24% |
Lisanti Capital Growth, LLC | 662,644 | $10,775,000 | 1.21% |
Baker Brothers Advisors | 12,710,818 | $206,678,000 | 1.19% |
Tamarack Advisers, LP | 125,000 | $2,033,000 | 0.96% |